Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 7,450 shares at $78.83 ($587K) on 2025-09-10, disclosed to the SEC on 2025-09-12.
Scheduled sale ($587k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.83 | 3,725 | $294K | 50.0% |
| 2 | $78.83 | 3,725 | $294K | 50.0% |
| Total | $78.83 avg | 7,450 | $587K | 100% |
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |